1.Effect of different cytokine combinations on the expression of CD49d and CXCR4 and ex vivo expansion of umbilical cord blood mononuclear cells.
Ping MAO ; Li XU ; Wen-Jian MO ; Yi YIN ; Yan-Li XU ; Xiu-Mei LIN
Journal of Experimental Hematology 2006;14(2):318-321
This study was purposed to explore the effect of different cytokine combinations on the expansion of the mononuclear cells drived from umbilical cord blood (CB) ex vivo and expression of CXCR4 and CD49d on CD34+ cells after expansion. Human fresh CB mononuclear cells were cultured in serum-free and stroma-free medium containing different combinations of cytokine for 7 days. At day o and 7, the total cells were counted, CD34+ cells and CD34+CXCR4+, CD34+CD49d+ cells were assayed by flow cytometry, and CFU were determined. According to the different combinations of cytokine, experiments were divided into four groups: control, SF group (SCF + FL), SFT group (SCF + FL + TPO) and SFT6 group (SCF + FL + TPO + IL-6). The results showed that the SF (SF group) combination supported only low expansion of total cells, CD34+ cells and CFU. The addition of TPO in SF group restored UCB stem/progenitors expansion to a higher level than that in SF group, while there was no difference between groups SFT and SFT6 (P > 0.05). The cytokine combinations in groups SF, SFT and SFT6 all could upregulate the expression levels of CD49d and CXCR4 on expanded cord blood CD34+ cells, but there were no significant differences between groups SF, SFT and SFT6 (P > 0.05). It is concluded that SCF + FL has no strong synergistic effects on primitive hematopoietic cells. TPO plays an important role in enhancing expansion of umbilical cord blood hematopoietic cells, while IL-6 only shows a neutral effect on it. SCF + FL + TPO combination not only promotes progenitor cells expansion but also upregulates the expression of CD49d and CXCR4 on CD34+ cells from cord blood.
Antigens, CD34
;
biosynthesis
;
genetics
;
Cytokines
;
pharmacology
;
Drug Synergism
;
Fetal Blood
;
cytology
;
Humans
;
Integrin alpha4
;
biosynthesis
;
genetics
;
Leukocytes, Mononuclear
;
cytology
;
Membrane Proteins
;
pharmacology
;
Receptors, CXCR4
;
biosynthesis
;
genetics
;
Stem Cell Factor
;
pharmacology
;
Thrombopoietin
;
pharmacology
2.House Dust Mite Induces Expression of Intercellular Adhesion Molecule-1 in EoL-1 Human Eosinophilic Leukemic Cells.
Byoung Chul KWON ; Myung Hyun SOHN ; Kyung Won KIM ; Eun Soo KIM ; Kyu Earn KIM ; Myeong Heon SHIN
Journal of Korean Medical Science 2007;22(5):815-819
The house dust mite (HDM) is considered to be the most common indoor allergen associated with bronchial asthma. In this study, we investigated whether crude extract of the HDM Dermatophagoides farinae could activate human eosinophilic leukemic cells (EoL-1) to induce upregulation of cell-surface adhesion molecules. When EoL-1 cells were incubated with D. farinae extract, expression of intercellular adhesion molecule-1 (ICAM-1) significantly increased on the cell surfaces compared to cells incubated with medium alone. In contrast, surface expression of CD11b and CD49d in EoL-1 cells was not affected by D. farinae extract. In addition, pretreatment of cells with NF- kappaB inhibitor (MG-132) or JNK inhibitor (SP600125) significantly inhibited ICAM-1 expression promoted by HDM extract. However, neither p38 MAP kinase inhibitor nor MEK inhibitor prevented HDM-induced ICAM-1 expression in EoL-1 cells. These results suggest that crude extract of D. farinae induces ICAM-1 expression in EoL-1 cells through signaling pathways involving both NF- kappaB and JNK.
Animals
;
Anthracenes/pharmacology
;
Antigens, CD11b/biosynthesis
;
Cell Line, Tumor
;
Cell Membrane/metabolism
;
Eosinophils/*metabolism
;
Flow Cytometry/methods
;
*Gene Expression Regulation
;
Humans
;
Integrin alpha4/biosynthesis
;
Intercellular Adhesion Molecule-1/*metabolism
;
Leukemia/*metabolism
;
Leupeptins/pharmacology
;
Mitogen-Activated Protein Kinase 8/metabolism
;
NF-kappa B/metabolism
;
Pyroglyphidae
;
p38 Mitogen-Activated Protein Kinases/metabolism
3.Change of adhesion molecule expression on CD34(+) cells from bone marrow and peripheral blood during mobilization with combination of chemotherapy and G-CSF.
Wan-Ming DA ; Miao ZHANG ; Bo-Long ZHANG ; Hai-Jie JIN ; Li YU ; Xiao-Ping HAN ; Yu JING ; Yu ZHAO ; Xiao-Xiong WU ; Wen-Rong HUANG ; Quan-Shun WANG
Journal of Experimental Hematology 2002;10(3):240-242
To explore the dynamic change of CD34(+) cell expressing adhesion molecules in bone marrow and peripheral blood during mobilization with combination of chemotherapy and G-CSF and its clinical significance, mononuclear cells of bone marrow and peripheral blood from malignant hematopathy cases before and after mobilization with G-CSF were labeled by CD45-CY-Chrome, PE conjugated anti-CD34, and FITC conjugated anti-CD44, anti-CD49d, anti-CD62L and anti-CXCR4. For three-color fluorescence analysis by flow cytometry was performed on a FACScalibur. Also the relationship between the number of subpopulations in different expressions of adhesion molecules infused and the time of recovery in different blood cells after transplantation was evaluated. Results showed that a significantly lower expression of CD44(+) and CD49d(+) on CD34(+) cells in bone marrow after mobilization compared to that before mobilization, whereas great higher expression of CD44(+), CD49d(+), anti-CD62L(+) and lower of anti-CXCR4(+) in peripheral blood were observed after mobilization. No significant relations were found between expression of different adhesion molecules on CD34(+) cells infused and the time of reconstitution in blood cells after transplantation. It was concluded that this mobilizing regimen could downregulate the expressions of CD44, CD49d, CD62L, and anti-CXCR4 on CD34(+) cells in bone marrow, it may related to mobilization of CD34(+) cells from marrow to blood, and homing of blood CD34(+) cells into marrow.
Adolescent
;
Adult
;
Antigens, CD34
;
immunology
;
Bone Marrow Cells
;
immunology
;
metabolism
;
Cell Adhesion Molecules
;
biosynthesis
;
blood
;
Female
;
Flow Cytometry
;
methods
;
Granulocyte Colony-Stimulating Factor
;
therapeutic use
;
Hematologic Neoplasms
;
immunology
;
metabolism
;
therapy
;
Hematopoietic Stem Cell Mobilization
;
Hematopoietic Stem Cell Transplantation
;
Hodgkin Disease
;
immunology
;
metabolism
;
therapy
;
Humans
;
Hyaluronan Receptors
;
biosynthesis
;
Integrin alpha4
;
biosynthesis
;
L-Selectin
;
biosynthesis
;
Leukocytes, Mononuclear
;
immunology
;
metabolism
;
Lymphoma, Non-Hodgkin
;
immunology
;
metabolism
;
therapy
;
Male
;
Middle Aged
;
Multiple Myeloma
;
immunology
;
metabolism
;
therapy
;
Precursor Cell Lymphoblastic Leukemia-Lymphoma
;
immunology
;
metabolism
;
therapy